Compare
Datacentrex, Inc. vs SideChannel, Inc. vs BioScience Health Innovations, Inc. vs HeartCore Enterprises, Inc.
| Latest fiscal year | Datacentrex, Inc. DTCX | SideChannel, Inc. SDCH | BioScience Health Innovations, Inc. BHIC | HeartCore Enterprises, Inc. HTCR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-09-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $6.96M | $7.35M | $5.69M | $8.97M |
| Revenue growth (YoY) | n/a | -0.7% | +208.3% | -60.5% |
| Gross margin | 48.9% | 47.7% | 57.0% | 35.1% |
| Operating margin | -113.7% | -12.5% | 12.6% | -34.8% |
| Net margin | -122.1% | -12.1% | 11.3% | 64.6% |
| Net income | -$8.50M | -$892.0K | $642.1K | $5.79M |
| EPS (Diluted) | -$0.46 | $0.00 | $0.06 | $0.22 |
| Operating cash flow | -$6.45M | -$130.0K | $172.2K | -$3.12M |
| Free cash flow | -$32.39M | n/a | n/a | n/a |
| Cash & equivalents | $38.92M | n/a | $661.9K | $1.99M |
| Total assets | $66.84M | $3.46M | $1.71M | $13.06M |
| Total liabilities | n/a | $1.32M | $229.9K | $5.78M |
| Shareholders' equity | $66.25M | $2.14M | $1.48M | $8.78M |
| Return on year-end equity | -12.8% | -41.6% | 43.5% | 66.0% |
| Shares outstanding | 30.38M | 231.23M | 10.98M | 25.42M |
Revenue, most recent five fiscal years
| Fiscal year | Datacentrex, Inc. | SideChannel, Inc. | BioScience Health Innovations, Inc. | HeartCore Enterprises, Inc. |
|---|---|---|---|---|
| Latest | $6.96M Ended 2025-12-31 | $7.35M Ended 2025-09-30 | $5.69M Ended 2025-12-31 | $8.97M Ended 2025-12-31 |
| 1 year earlier | $741 Ended 2024-12-31 | $7.40M Ended 2024-09-30 | $1.84M Ended 2024-12-31 | $22.69M Ended 2024-12-31 |
| 2 years earlier | $2.0K Ended 2023-12-31 | $6.57M Ended 2023-09-30 | $597.6K Ended 2023-12-31 | $21.85M Ended 2023-12-31 |
| 3 years earlier | $2.4K Ended 2022-12-31 | $4.79M Ended 2022-09-30 | $69.3K Ended 2022-12-31 | $8.82M Ended 2022-12-31 |
| 4 years earlier | $2.4K Ended 2021-12-31 | $2.80M Ended 2021-09-30 | n/a | $10.82M Ended 2021-12-31 |